Midland Memorial Hospital has received the American Heart Association’s Get With The Guidelines – Coronary Artery Disease, NSTEMI Gold with Target: Type 2 Diabetes recognition for its commitment to offering rapid, research-based care to people experiencing a specific type of heart attack known as a non-ST elevation myocardial infarction (NSTEMI).
Each year, more than 546,000 people experience this type of dangerous heart attack, caused by a partial blockage of blood flow to the heart.
Like all heart attacks, this requires timely treatment to restore blood flow as quickly as possible.
“In the event of an NSTEMI heart attack, adherence to the American Heart Association’s guidelines is critical. These guidelines include specific recommendations for in-hospital care and cardiac rehabilitation post-discharge,” said Dr. Abhinav Goya. “Midland Memorial Hospital is among the institutions recognized for consistently providing patients with evidence-based NSTEMI care, which offers the best chance of preventing another heart attack.”
The NSTEMI Center award is earned by hospitals that demonstrate a commitment to treating patients according to the most up-to-date, research-based guidelines for NSTEMI care as outlined by the American Heart Association.
“MMH is honored to be recognized by the American Heart Association for our dedication to providing optimal care for heart attack patients,” President and CEO Stephen Bowerman said in a news release. “The Mission: Lifeline program puts proven knowledge and guidelines to work on a daily basis, so patients have the best possible chance of survival.”
Midland Memorial Hospital also received the American Heart Association’s Target: Type 2 Diabetes™ Honor Roll award, for aiming to ensure patients with Type 2 diabetes receive the most up-to-date, evidence-based care when hospitalized due to heart attack, the release said.
